Nurix Therapeutics (NRIX) Profit After Tax (2019 - 2025)
Historic Profit After Tax for Nurix Therapeutics (NRIX) over the last 7 years, with Q4 2025 value amounting to -$78.2 million.
- Nurix Therapeutics' Profit After Tax fell 3359.92% to -$78.2 million in Q4 2025 from the same period last year, while for Nov 2025 it was -$264.5 million, marking a year-over-year decrease of 3662.16%. This contributed to the annual value of -$264.5 million for FY2025, which is 3662.16% down from last year.
- Latest data reveals that Nurix Therapeutics reported Profit After Tax of -$78.2 million as of Q4 2025, which was down 3359.92% from -$86.4 million recorded in Q3 2025.
- In the past 5 years, Nurix Therapeutics' Profit After Tax registered a high of -$24.3 million during Q1 2021, and its lowest value of -$86.4 million during Q3 2025.
- In the last 5 years, Nurix Therapeutics' Profit After Tax had a median value of -$43.0 million in 2022 and averaged -$45.0 million.
- In the last 5 years, Nurix Therapeutics' Profit After Tax tumbled by 44804.75% in 2021 and then skyrocketed by 4652.76% in 2023.
- Quarter analysis of 5 years shows Nurix Therapeutics' Profit After Tax stood at -$37.7 million in 2021, then dropped by 23.91% to -$46.7 million in 2022, then increased by 10.19% to -$42.0 million in 2023, then plummeted by 39.55% to -$58.5 million in 2024, then crashed by 33.6% to -$78.2 million in 2025.
- Its Profit After Tax was -$78.2 million in Q4 2025, compared to -$86.4 million in Q3 2025 and -$43.5 million in Q2 2025.